No Data
宏力醫療管理：2024年中期報告
honliv health (09906) announced its interim results, with a net profit attributable to owners of 20.042 million yuan, a decrease of 17.4% year-on-year.
Honliv Health (09906) announced its mid-term performance for 2024, with revenue of approximately 0.415 billion yuan, a year-on-year growth of 12...
HONLIV HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Honliv Health (09906.HK) will hold a board of directors meeting on August 30th to approve its mid-term performance.
Honliv Health (09906.HK) announced on August 20th that the company will hold a board of directors meeting on August 30, 2024 to consider and approve the interim performance announcement of the company and its subsidiaries for the six months ending on June 30, 2024, as well as the payment of interim dividends (if any).
Honliv Health (09906.HK): Yang Zhaolin was appointed as the joint company secretary and authorized representative.
Honliv Health (09906.HK) announced on August 19th that Xu Yanshan has resigned as the company's joint company secretary and no longer serves as the company's authorized representative for Securities Listing Rule 3.05 of the Hong Kong Stock Exchange and authorized representative for receiving legal proceedings or notices on behalf of the company in Hong Kong in accordance with the Company's Articles (Chapter 622 of the Laws of Hong Kong). Yang Zhaolin has been appointed to replace Xu as joint company secretary and authorized representative, effective August 19, 2024.
Express News | Honliv Healthcare Management - Chen Zhiyong Appointed as Vice President of Co
No Data
No Data